ICARS: ENGINEERED SAFETY FOR T CELL IMMUNOTHERAPY

被引：0
|
作者：
Fedorov, V. [1 ]
Themeli, M. [1 ]
Sadelain, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB2449
引用
收藏
页码：796 / 796
页数：1
相关论文
共 50 条
  • [21] Genetically engineered T cells for cancer immunotherapy
    Li, Dan
    Li, Xue
    Zhou, Wei-Lin
    Huang, Yong
    Liang, Xiao
    Jiang, Lin
    Yang, Xiao
    Sun, Jie
    Li, Zonghai
    Han, Wei-Dong
    Wang, Wei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [22] Safety of engineered allergen-specific immunotherapy vaccines
    Focke-Tejkl, Margarete
    Valenta, Rudolf
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 12 (05) : 555 - 563
  • [23] Hematopoietic stem/progenitor cells engineered with T cell receptors for immunotherapy for HIV infection
    Joglekar, Alok
    Sandoval, Salemiz
    Jeppson, John
    Liu, Zhe
    Leonard, Michael Troy
    Swift, Margaret
    Baltimore, David
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [24] Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
    Zhao, Qijie
    Jiang, Yu
    Xiang, Shixin
    Kaboli, Parham Jabbarzadeh
    Shen, Jing
    Zhao, Yueshui
    Wu, Xu
    Du, Fukuan
    Li, Mingxing
    Cho, Chi Hin
    Li, Jing
    Wen, Qinglian
    Liu, Tao
    Yi, Tao
    Xiao, Zhangang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Engineered T cell transfer for cancer immunotherapy in the era of synthetic biology: Challenges and opportunities
    June, Carl H.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [26] Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
    Huang, Qiaolin
    Zhu, Xiaojian
    Zhang, Yicheng
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [27] Teaching your body to fight cancer with gene-engineered T cell immunotherapy
    Johnson, Laura
    JOURNAL OF HISTOTECHNOLOGY, 2019, 42 (04) : 168 - 168
  • [28] In Vitro Cell Based Cytotoxicity and T Cell Activation Assays to Assess Safety and Efficacy of Engineered T Cell Therapies
    Holt, Sanne
    Vermond, Sophie
    Hazenoot, Monique
    Overman, Jeroen
    Aarbiou, Jamil
    DeGroot, Jeroen
    MOLECULAR THERAPY, 2020, 28 (04) : 515 - 515
  • [29] In vitro cell based cytotoxicity and T cell activation assays to assess safety and efficacy of engineered T cell therapies
    Holt, Sanne
    Vermond, Sophie
    Hazenoot, Monique Hazenoot
    Overman, Jeroen
    Aarbiou, Jamil Aarbiou
    DeGroot, Jeroen DeGroot
    CANCER RESEARCH, 2020, 80 (16)
  • [30] Identifying cancer-specific T cells for TCR T-cell immunotherapy through engineered proteins
    Zhang, Rongyu
    Ng, Rachel
    Mckasson, Michaela
    Chour, William
    Webster, Andrew
    Choi, Jongchan
    Xie, Jingyi
    Trimble, Cornelia
    Ribas, Antoni
    Heath, James
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
12345